540729 VANTABIO

Vanta Bioscience Share Price

₹41.07 +1.94 (4.96%)

21 Nov, 2024 21:13

SIP TrendupStart SIP in VANTABIO

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 0.15%
  • Over 3 Month -24.06%
  • Over 6 Month -44.12%
  • Over 1 Year -23.94%
SIP Lightning

Smart Investing Starts Here Start SIP with Vanta Bioscience for Steady Growth!

Invest Now

Vanta Bioscience Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Vanta Bioscience Financials

Vanta Bioscience Technicals

EMA & SMA

Current Price
₹41.07
+ 1.94 (4.96%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹45.20
  • 50 Day
  • ₹47.92
  • 100 Day
  • ₹51.91
  • 200 Day
  • ₹59.28

Resistance and Support

39.81 Pivot Speed
  • R3 46.12
  • R2 43.60
  • R1 42.33
  • S1 38.54
  • S2 36.02
  • S3 34.75

What's your outlook on Vanta Bioscience?

You can only vote for once

Vanta Bioscience Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Half Yearly Results
2024-07-19 Audited Results
2024-07-17 Audited Results
2023-11-14 Half Yearly Results
2023-08-10 Audited Results

Vanta Bioscience F&O

Vanta Bioscience Shareholding Pattern

No data available.

About Vanta Bioscience

  • NSE Symbol
  • VANTABIO
  • BSE Symbol
  • 540729
  • ISIN
  • INE695X01011

Similar Stocks to Vanta Bioscience

Vanta Bioscience FAQs

Vanta Bioscience share price is ₹41 As on 21 November, 2024 | 20:59

The Market Cap of Vanta Bioscience is ₹25.9 Cr As on 21 November, 2024 | 20:59

The P/E ratio of Vanta Bioscience is As on 21 November, 2024 | 20:59

The PB ratio of Vanta Bioscience is 2 As on 21 November, 2024 | 20:59

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23